Aslan Fred sold ARTV
October 17, 2025 · Form 4 insider transaction
Aslan Fred sold 25,500 shares of Artiva Biotherapeutics, Inc. at $6.00 per share, a transaction worth $153.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
25,500
Price
$6.00
Total value
$153.0K
InsiderAslan Fred
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 17, 2025
Filing dateOctober 17, 2025
Shares owned after356,721
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024.